MedPath

Polyethylene Glycol 3350

Polyethelene Glycol 3350 Powder for OralSolution

Approved
Approval ID

3729a1d2-4c98-dfdf-e063-6394a90a5a87

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Jun 9, 2025

Manufacturers
FDA

Kesin Pharma Corporation

DUNS: 117447816

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Polyethylene Glycol 3350

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code81033-762
Application NumberANDA203928
Product Classification
M
Marketing Category
C73584
G
Generic Name
Polyethylene Glycol 3350
Product Specifications
Route of AdministrationORAL
Effective DateJune 9, 2025
FDA Product Classification

INGREDIENTS (1)

POLYETHYLENE GLYCOL 3350Active
Quantity: 17 g in 17 g
Code: G2M7P15E5P
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 6/9/2025

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 81033-762-01

Polyethylene Glycol 3350 Powder for Oral Solution

Osmotic laxative

100 Packets

(100 once-daily doses)

PEG3350Powder_100count_Carton

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 6/9/2025

Use

  • relieves occasional constipation (irregularity)
  • generally produces a bowel movement in 1 to 3 days

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 6/6/2025

TAMPER-EVIDENT: DO NOT USE IF FOIL IS OPEN OR BROKEN

*This product is not manufactured by Bay HealthCare LLC, owner of the registered trademark MiraLAX ®

Distributed by:

Kesin Pharma

Oldsmar, FL 34677

Kesin Pharma Logo

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 6/9/2025

Active ingredient (in each dose)

Polyethlene Glycol 3350, 17 g

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 6/9/2025

Purpose

Osmotic Laxative

WARNINGS SECTION

LOINC: 34071-1Updated: 2/18/2022

Warnings

Allergy alert:

Do not use if you are allergic to polyethylene glycol

Do not use

if you have kidney disease, except under the advice and supervision of a doctor

Ask a doctor before use if you have

  • nausea, vomiting or abdominal pain
  • a sudden change in bowel habits that lasts over 2 weeks
  • irritable bowel syndrome

Ask a doctor or pharmacist before use if you are taking

a prescription drug

When using this product

you may have loose, watery, more frequent stools

Stop use and ask a doctor if

  • you have rectal bleeding or your nausea, bloating, cramping or abdominal pain gets worse. These may be signs of a serious condition.
  • you need to use a laxative for longer than 1 week
  • you get diarrhea

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of the reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 6/9/2025

Directions

*do not take more than directed unless advised by your doctor

  • adults and children 17 yearsof age and older:
  • use once a day
  • stir and dissolve one packet of powder (17 g) in any 4 to 8 ounce of beverage (cold, hot or room temperature) then drink
  • do not combine with starch-based thickners used for difficulty swallowing
  • ensure that the powder is fully dissolved before drinking
  • do not drink if there are any clumps
  • do not use more than 7 days
  • children 16 years of age or under: ask a doctor

OTHER SAFETY INFORMATION

LOINC: 60561-8Updated: 6/9/2025

Other information

  • store at 20°C to 25°C (68°F to 77°F) *tamper-evident: do not use if printed foil pouch is open or broken *this package is not child-resistant

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 6/9/2025

Inactive ingredients

none

OTC - QUESTIONS SECTION

LOINC: 53413-1Updated: 2/18/2022

Questions or comments?

Call 1-833-537-4679

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Polyethylene Glycol 3350 - FDA Drug Approval Details